Why the study?
Do third-generation oral contraceptives affect blood pressure and vascular reactivity in women?
Do third-generation oral contraceptives affect blood pressure and vascular reactivity in women?
Third-generation oral contraceptives increase vascular resistance in the axillary artery without significantly impacting resting blood pressure.
Third-generation OCs were associated with higher axillary pulsatility without BP change; leaves open long-term vascular risk and needs prospective confirmation.
Blood pressure and great vessel vascular reactivity, evaluated by color Doppler ultrasound, were investigated in users of third-generation oral contraceptives (n = 18) compared to non-users, who were studied either in the follicular (n = 8) or in the luteal (n = 10) phase of the menstrual cycle. Blood pressure measured at rest in the supine position, evaluated both in the follicular phase and in the luteal phase, was similar between oral contraceptive users and non-users. The pulsatility index (an indirect index of resistance to blood flow) of both the internal carotid artery and the axillary artery was similar in control women studied in the follicular phase and in the luteal phase. By contrast, in users of oral contraceptives, pulsatility index values of the internal carotid artery tended to be higher, whilst those of the axillary artery were significantly higher, than those of women in either the follicular phase (p < 0.01) or the luteal phase (p < 0.025). In conclusion, new third-generation oral contraceptives do not have a significant impact on blood pressure control, but still tend to increase vascular resistance to blood flow, particularly in areas more involved in the regulation of blood pressure, for example the axillary artery.
No takes yet. Share an insight, caveat, or question.
Cagnacci et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: